- Home
- ATMVU vs FBIOP Comparison
ATMVU vs FBIOP Comparison
Compare ATMVU & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATMVU
- FBIOP
- Stock Information
- Founded
- ATMVU N/A
- FBIOP N/A
- Country
- ATMVU
- FBIOP United States
- Employees
- ATMVU 2
- FBIOP 101
- Industry
- ATMVU
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- ATMVU
- FBIOP Health Care
- Exchange
- ATMVU NYSE
- FBIOP Nasdaq
- Market Cap
- ATMVU N/A
- FBIOP N/A
- IPO Year
- ATMVU N/A
- FBIOP N/A
- Fundamental
- Price
- ATMVU $11.85
- FBIOP $7.10
- Analyst Decision
- ATMVU
- FBIOP
- Analyst Count
- ATMVU 0
- FBIOP 0
- Target Price
- ATMVU N/A
- FBIOP N/A
- AVG Volume (30 Days)
- ATMVU N/A
- FBIOP N/A
- Earning Date
- ATMVU N/A
- FBIOP N/A
- Dividend Yield
- ATMVU N/A
- FBIOP N/A
- EPS Growth
- ATMVU N/A
- FBIOP N/A
- EPS
- ATMVU N/A
- FBIOP N/A
- Revenue
- ATMVU N/A
- FBIOP N/A
- Revenue This Year
- ATMVU N/A
- FBIOP N/A
- Revenue Next Year
- ATMVU N/A
- FBIOP N/A
- P/E Ratio
- ATMVU N/A
- FBIOP N/A
- Revenue Growth
- ATMVU N/A
- FBIOP N/A
- 52 Week Low
- ATMVU N/A
- FBIOP N/A
- 52 Week High
- ATMVU N/A
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- ATMVU 99.02
- FBIOP 38.19
- Support Level
- ATMVU $11.30
- FBIOP $6.51
- Resistance Level
- ATMVU N/A
- FBIOP $7.46
- Average True Range (ATR)
- ATMVU 0.00
- FBIOP 0.48
- MACD
- ATMVU -0.01
- FBIOP -0.14
- Stochastic Oscillator
- ATMVU 0.00
- FBIOP 27.49
About ATMVU ALPHAVEST ACQUISITION CORP
AlphaVest Acquisition Corp is a blank check company.
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.